Download full report with analyst certification and important disclosures
May 2 2024, 08:00 IST/BST
Dsm-firmenich has delivered a solid start to FY24, with Q1 EBITDA in line with expectations. Group performance was supported by strong fragrance demand within Perfumery & Beauty (P&B), and Taste, Texture & Health (TTH) seeing improved end-market momentum with destocking normalising. Animal Nutrition was weaker than expected. FY24 EBITDA guidance is unchanged, with management remaining cautious as to the robustness of market recovery trends. As such, we envisage limited changes to our forecasts.
May 2 2024, 08:00 IST/BST